InflaRx NV buy Guggenheim
Start price
26.03.25
/
50%
€1.21
Target price
26.03.26
€9.27
Performance (%)
-35.50%
End price
27.03.26
€0.78
Summary
This prediction ended on 27.03.26 with a price of €0.78. Massive losses of -35.50% were the result for the BUY prediction by Guggenheim. Guggenheim has a follow-up prediction for InflaRx NV where he still thinks InflaRx NV is a Buy. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| InflaRx NV | 32.534% | 32.534% | 17.788% |
| iShares Core DAX® | 0.985% | 8.314% | 7.032% |
| iShares Nasdaq 100 | 2.067% | 16.765% | 35.952% |
| iShares Nikkei 225® | 2.270% | 15.605% | 46.568% |
| iShares S&P 500 | 1.043% | 11.077% | 26.456% |
Comments by Guggenheim for this prediction
In the thread InflaRx NV diskutieren
InflaRx (NASDAQ: IFRX) had its price target raised by analysts at Guggenheim from $7.00 to $10.00. They now have a "buy" rating on the stock.
Ratings data for IFRX provided by MarketBeat
In the thread Trading InflaRx NV
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten